Related Experiment Video
Updated: Nov 11, 2025

Measuring the Carotid to Femoral Pulse Wave Velocity Cf-PWV to Evaluate Arterial Stiffness
Published on: May 3, 2018
AST/ALT Ratio and Peripheral Artery Disease in a Chinese Hypertensive Population: A Cross-Sectional Study
Hui Liu1, Xiaoyuan Zha2, Congcong Ding1
1Department of Cardiovascular Medicine, 196534The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, People's Republic of China.
Insights
The aspartate aminotransferase (AST) to alanine aminotransferase (ALT) ratio (AST/ALT) is linked to higher peripheral artery disease (PAD) risk in hypertensive Chinese adults. This ratio may help identify individuals at increased risk for vascular issues.
Area of Science:
- Cardiology
- Hepatology
- Vascular Medicine
Background:
- The aspartate aminotransferase (AST) to alanine aminotransferase (ALT) ratio (AST/ALT) is a known cardiovascular disease risk factor.
- Peripheral artery disease (PAD) significantly increases the risk of cardiovascular mortality.
- Limited research exists on the association between the AST/ALT ratio and PAD.
Purpose of the Study:
- To investigate the correlation between the AST/ALT ratio and the risk of PAD in hypertensive patients.
- To determine if the AST/ALT ratio can serve as a predictive marker for PAD in this population.
Main Methods:
- Analysis of data from 10,900 hypertensive patients from the Chinese Hypertension Registry Study.
- Statistical adjustment for potential confounding factors.
- Assessment of PAD prevalence and its association with varying AST/ALT ratio levels (tertiles).
Main Results:
- A prevalence of 3.2% for PAD was observed (350 patients).
- The AST/ALT ratio was independently and positively associated with PAD risk (OR: 1.31).
- Higher AST/ALT ratio tertiles showed a significantly increased risk of PAD, with a trend (P = .005). A ratio ≥1.65 was associated with PAD risk.
Conclusions:
- The AST/ALT ratio is independently associated with an increased risk of PAD in Chinese adults with hypertension.
- This ratio may serve as a practical, cost-effective tool for identifying high-risk individuals for vascular events and atherosclerosis.
- Further research could validate the AST/ALT ratio as a screening tool for PAD.
Abstract:
Previous studies reported that the aspartate aminotransferase (AST) to alanine aminotransferase (ALT) ratio (AST/ALT) was a risk factor in cardiovascular disease. Peripheral artery disease (PAD) is an important risk factor for cardiovascular death. However, only a few studies investigated the correlations between the AST/ALT ratio and PAD. We analyzed data from 10 900 patients with hypertension from the Chinese Hypertension Registry Study; 350 patients had PAD (prevalence 3.2%). After adjusting for potential confounders, the AST/ALT ratio was independently and positively associated with risk of PAD (OR: 1.31, 95% CI, 1.13-1.59), and a significant increased risk of PAD for the third AST/ALT ratio tertile (T3) compared with the first tertile (T1; OR: 1.49, 95% CI, 1.09-2.04, Ptrend = .005) was found. Moreover, when we combined T1 and T2 into one group and used it as a reference group, the risk of PAD increased with the increase in AST/ALT; the risk ratio was 1.52 (95% CI, 1.20-1.95). A higher AST/ALT ratio (≥1.65) was associated with PAD risk in Chinese adults with hypertension. Our results suggest that the AST/ALT ratio may help identify patients at high risk of vascular end points and might be a convenient, economical, and effective tool for evaluating the risk of atherosclerosis.
More Related Videos
Related Concept Videos
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Peripheral Artery Disease I: Introduction
Special considerations while measuring blood pressure
Monitoring Both Arms:
Monitoring BP in both arms during the initial assessment is advisable, as the systolic value may differ by five to ten mm Hg between arms. For subsequent BP assessments, use the arm with the higher reading.
Pre-Procedural Guidelines for Assessing Blood Pressure
Hypertension III: Clinical Manifestations and Diagnostic Studies
Hypertension II: Pathophysiology

